definiens: means a anthrax vaccine generally as described in Broad Agency AnnouncementBAA NIH - BARDA - NIAID - DMID - AI2007007 ; means an amount equal to 1 % of all Relevant 3 G Sales ; means the Milestone 1 Condition, the Milestone 2A Development Condition, the Milestone 2AProcurement Condition, the achievement of Relevant rPA Sales in excess of 25 million doses of rPA Vaccine and theachievement of any Relevant 3 G Sales ; means the entry by any member of the Purchaser ’s Group into a multi - year funded contract with theUS Department of Defence ( or other agency or representative or sub - contractor of the US government ) for the furtherdevelopment of the rYP Vaccine as a result of ( i ) a Resources Allocation Decision of the Resource Allocation Review Boardand the Resource Allocation Advisory Committee of the US Department of Defence ( or any alternative or successor agency)or ( ii ) some other similar substantial funding in excess of US$ 150 million ( including the value of any optional elementswithin such contract ) ; means the sum of US$ 10 million ; means the entry by any member of the Purchaser ’s Group into a multi - year fundeddevelopment contract to be issued by the Biological Advanced Research and Development Authority ( part of the USDepartment of Health and Human Services ) ( or any alternative or successor agency ) under solicitation number RFP - BARDA-08 - 15 ( or any substitution or replacement thereof ) ; means the sum of US$ 5 million ; means the entry into by any member of the Purchaser ’s Group of a contract orcontracts for the supply of rPA Vaccine into the Strategic National Stockpile ( which for the avoidance of doubt may be thesame contract as gives rise to the satisfaction of the Milestone 2A Development Condition ) ; means the sum of US$ 5 million ; means Net Sales of 3 G Anthrax Vaccine made within the period of 10 years from the Completion Dateby any member of the Purchaser ’s Group to the US government ( or otherwise into the Strategic National Stockpile ) where NetSales means the gross amount billed by any member of the Purchaser ’s group to the US government ( or otherwise into theStrategic National Stockpile of 3 G Anthrax 46 Vaccine ), less the following ( i ) customary trade, quantity or cash discounts to the extent actually allowed and taken;(ii ) amounts repaid or credited by reason of rejection or return ; ( iii ) to the extent separately stated on purchase order, invoicesor other documents of sale, any taxes or other governmental charges levied on the production, sale, transportation, delivery oruse of any 3 G Anthrax Vaccine which is paid by or on behalf of any member of the Purchaser ’s Group ; ( iv ) outboundtransportation costs prepaid or allowed and costs of insurance in transit, in each case in respect of deliveries outside the US;(vi ) costs of delivery devices or delivery systems used for dispensing or administering product to the extent these exceed thecost of such devices or systems used by the Target Business in clinical trials before the date of this Agreement ; and(vi ) deductions for premiums for government mandated insurance ; ; means Net Sales of rPA Vaccine made within the period of 10 years from the Completion Date by anymember of the Purchaser ’s Group to the US government ( or otherwise into the Strategic National Stockpile ) where Net Salesmeans the gross amount billed by any member of the Purchaser ’s group to the US government ( or otherwise into the StrategicNational Stockpile of rPA Vaccine, less the following ( i ) customary trade, quantity or cash discounts to the extent actuallyallowed and taken ; ( ii ) amounts repaid or credited by reason of rejection or return ; ( iii ) to the extent separately stated onpurchase order, invoices or other documents of sale, any taxes or other governmental charges levied on the production, sale, transportation, delivery or use of any rPA Vaccine which is paid by or on behalf of any member of the Purchaser ’s Group;(iv ) outbound transportation costs prepaid or allowed and costs of insurance in transit, in each case in respect of deliveriesoutside the US ; ( vi ) costs of delivery devices or delivery systems used for dispensing or administering product to the extentthese exceed the cost of such devices or systems used by the Target Business in clinical trials before the date of thisAgreement ; and ( vii ) deductions for premiums for government mandated insurance ; means an amount equal to 2.5 % of all Relevant rPA Sales after the first 25 million doses of rPAVaccine ; means a recombinant protective antigen vaccine against anthrax ; means a Yersinia pestis vaccine ( comprising rF1 and rV recombinant antigens ) against pneumonic or bubonicplague ; and means the strategic national stockpile administered by or on behalf of the Centers for DiseaseControl and Prevention ( part of the US Department of Health and Human Services ) ( or any alternative or successor agency orstockpiling process )